Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christoph Wanner

Showing results (201-210 of 785) with videos related to

Pageof 79
Sort By:
JIMD Reports|October 27, 2015
Electrical Changes in Resting, Exercise, and Holter Electrocardiography in Fabry CardiomyopathyJohannes Krämer, Peter Nordbeck, Stefan Störk, et al.
Annals of Internal Medicine|August 23, 2012
Lipid-lowering therapy in persons with chronic kidney disease: a systematic review and meta-analysisAshish Upadhyay, Amy Earley, Jenny L Lamont, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 2, 2023
Hyponatraemia and fluid overload are associated with higher risk of mortality in dialysis patientsJule Pinter, Bernd Genser, Ulrich Moissl, et al.
BMC Nephrology|March 26, 2013
Predicting erythropoietin resistance in hemodialysis patients with type 2 diabetesAndreas Schneider, Markus P Schneider, Hubert Scharnagl, et al.
Journal of the American Society of Nephrology : JASN|March 19, 2011
Copeptin levels associate with cardiovascular events in patients with ESRD and type 2 diabetes mellitusWiebke Fenske, Christoph Wanner, Bruno Allolio, et al.
NDT Plus|January 20, 2011
The 2008 ERA-EDTA Registry Annual Report-a précisVianda S Stel, Moniek W M van de Luijtgaarden, Christoph Wanner, et al.
Artificial Organs|January 8, 2014
Clearance of drugs for multiple myeloma therapy during in vitro high-cutoff hemodialysisDetlef H Krieter, Eric Devine, Christoph Wanner, et al.
European Journal of Medical Genetics|June 14, 2019
Why systematic literature reviews in Fabry disease should include all published evidencePerry M Elliott, Dominique P Germain, Max J Hilz, et al.
Clinical Chemistry|October 15, 2016
High Glycated Albumin and Mortality in Persons with Diabetes Mellitus on HemodialysisChristina W Chen, Christiane Drechsler, Pirianthini Suntharalingam, et al.
Cardiovascular Diabetology|August 4, 2022
Cardiovascular outcomes trials: a paradigm shift in the current management of type 2 diabetesMelanie J Davies, Heinz Drexel, François R Jornayvaz, et al.
Pageof 79

Showing results (201-210 of 785) with videos related to

Sort By:
Pageof 79
JIMD Reports|October 27, 2015
Electrical Changes in Resting, Exercise, and Holter Electrocardiography in Fabry CardiomyopathyJohannes Krämer, Peter Nordbeck, Stefan Störk, et al.
Annals of Internal Medicine|August 23, 2012
Lipid-lowering therapy in persons with chronic kidney disease: a systematic review and meta-analysisAshish Upadhyay, Amy Earley, Jenny L Lamont, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 2, 2023
Hyponatraemia and fluid overload are associated with higher risk of mortality in dialysis patientsJule Pinter, Bernd Genser, Ulrich Moissl, et al.
BMC Nephrology|March 26, 2013
Predicting erythropoietin resistance in hemodialysis patients with type 2 diabetesAndreas Schneider, Markus P Schneider, Hubert Scharnagl, et al.
Journal of the American Society of Nephrology : JASN|March 19, 2011
Copeptin levels associate with cardiovascular events in patients with ESRD and type 2 diabetes mellitusWiebke Fenske, Christoph Wanner, Bruno Allolio, et al.
NDT Plus|January 20, 2011
The 2008 ERA-EDTA Registry Annual Report-a précisVianda S Stel, Moniek W M van de Luijtgaarden, Christoph Wanner, et al.
Artificial Organs|January 8, 2014
Clearance of drugs for multiple myeloma therapy during in vitro high-cutoff hemodialysisDetlef H Krieter, Eric Devine, Christoph Wanner, et al.
European Journal of Medical Genetics|June 14, 2019
Why systematic literature reviews in Fabry disease should include all published evidencePerry M Elliott, Dominique P Germain, Max J Hilz, et al.
Clinical Chemistry|October 15, 2016
High Glycated Albumin and Mortality in Persons with Diabetes Mellitus on HemodialysisChristina W Chen, Christiane Drechsler, Pirianthini Suntharalingam, et al.
Cardiovascular Diabetology|August 4, 2022
Cardiovascular outcomes trials: a paradigm shift in the current management of type 2 diabetesMelanie J Davies, Heinz Drexel, François R Jornayvaz, et al.
Pageof 79